Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Seebri Breezhaler 44microgram inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0301020S0BBAAAA |
| Virtual Medicinal Product | Glycopyrronium bromide 55microgram inhalation powder capsules with device |
| Name | Seebri Breezhaler 44microgram inhalation powder capsules with device |
| Abbreviated name | Seebri Breezhaler 44microgram inhalation pdr caps with dev |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| Seebri Breezhaler 44microgram inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) 10 capsule | |
| Seebri Breezhaler 44microgram inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) 30 capsule 3 x 10 capsules | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.